Literature DB >> 977953

Solubilization of IgA immune precipitates by complement.

G W Miller.   

Abstract

The complement (C) system can solubilize immune precipitates prepared with antibodies of the IgG class, and apparently also of the IgM class. This paper shows that C can also solubilize immune precipitates prepared with two different antigen-binding IgA myeloma proteins. Immune precipitates were prepared with a) mouse myeloma protein TEPC 15 and PC-KLH, and b) mouse myeloma protein MOPC 315 and DNP-BSA. The precipitates could be solubilized by fresh mouse serum, but not by zymosan- or heat-inactivated serum. The rate of solubilization was not affected by the removal of of Ca++ ions. These results verify that the C-mediated solubilization effect can proceed entirely via the alternative C pathway, and lend increased support to the view that the effect is a general phenomenon, not restricted to a particular antibody class or type of antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977953

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

2.  Activation of mouse complement by different classes of mouse antibody.

Authors:  G G Klaus; M B Pepys; K Kitajima; B A Askonas
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

3.  The juxtaglomerular apparatus in IgA nephropathy: an analysis of the transport and fate of IgA deposits at the glomerular hilus.

Authors:  M Hara; K Honda; S Matsuya; Y Endo; S Hara; Y Suzuki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

4.  Molecular composition of complement-solubilized complexes and their fate in vivo.

Authors:  P Malasit; S R Bartolotti; J H Humphrey
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

5.  Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.

Authors:  G Pfaffenbach; M E Lamm; I Gigli
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.